Functional (non-ulcer) dyspepsia: Unexplained but not unmanageable

Medical Journal of Australia

Volumn 168, Issue 10, 1998, Pages 507-512

  Hu, Wayne H C ^a   Talley, Nicholas J ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

PROKINETIC AGENT; STOMACH SECRETION INHIBITOR;

ABDOMINAL DISCOMFORT; ABDOMINAL PAIN; ARTICLE; DYSPEPSIA; EPIGASTRIC PAIN; HUMAN; MORBIDITY; NAUSEA;

EID: 0032543162     PISSN: 0025729X     EISSN: None     Source Type: Journal    
DOI: 10.5694/j.1326-5377.1998.tb141419.x     Document Type: Article

References (56)

1. Talley NJ, Colin-Jones D, Koch KL, et al. Functional dyspepsia: a classification with guidelines for diagnosis and management. Gastroenterol Intl 1991; 4: 145-160.
2. Klauser AG, Schindlbeck NE, Muller Lissner SA. Symptoms in gastro-oesophageal reflux disease. Lancet 1990; 335: 205-208.
3. Talley NJ, Zinsmeister AR, Schleck CD, Melton LJ, 3d. Dyspepsia and dyspepsia subgroups: a population-based study. Gastroenterology 1992; 102: 1259-1268
4. Holtmann G, Goebell H, Holtmann M, Talley NJ. Dyspepsia in healthy blood donors: pattern of symptoms and association with Helicobacter pylori. Dig Dis Sci 1994; 39: 1090-1098
5. Talley NJ, Weaver AL, Tesmer DL, Zinsmeister AR. Lack of discriminant value of dyspepsia subgroups in patients referred for upper endoscopy. Gastroenterology 1993; 105: 1378-1386.
6. Heading RC, Dyspepsia study group. Upper gastrointestinal symptoms in general practice: a multicentre UK study. J Drug Dev Clin Pract 1995; 7: 109-117.
7. Scott AM, Kellow JE, Shuter B, et al. Intragastric distribution and gastric emptying of solids and liquids in functional dyspepsia. Lack of influence of symptom subgroups and H. pylori-associated gastritis. Dig Dis Sci 1993; 38: 2247-2254.
8. Stanghellini V, Tosetti C, Paternico A, et al. Risk indicators of delayed gastric emptying of solids in patients with functional dyspepsia. Gastroenterology 1996; 110: 1036-1042.
9. Small PK, Loudon MA, Waldron B, et al. Importance of reflux symptoms in functional dyspepsia. Gut 1995; 36: 189-192.
10. David D, Mertz H, Fefer L, et al Sleep and duodenal motor activity in patients with severe non-ulcer dyspepsia. Gut 1994; 35: 916-925.
11. Jones R, Lydeard S. Dyspepsia in the community: a follow-up study. Br J Clin Pract 1992; 46: 95-97.
12. Talley NJ, Weaver AI, Zinsmeister AR, Melton LJ, 3d. Onset and disappearance of gastrointestinal symptoms and functional gastrointestinal disorders. Am J Epidemiol 1992; 136: 165-177.
13. Agreus L, Svardsudd K, Nyren O, Tibblin G. Irritable bowel syndrome and dyspepsia in the general population: overlap and lack of stability over time. Gastroenterology 1995; 109: 671-680.
14. Nyren O, Lindberg G, Lindstrom E, et al. Economic costs of functional dyspepsia. PharmacoEconomics 1992; 1: 312-324.
15. Tucci A, Corinaldesi R, Stanghellini V, et al. Helicobacter pylori infection and gastric function in patients with chronic idiopathic dyspepsia. Gastroenterology 1992; 103: 768-774.
16. El-Omar E, Penman I, Ardill JES, McColl KEL. A substantial proportion of non-ulcer dyspepsia patients have the same abnormality of acid secretion as duodenal ulcer patients. Gut 1995; 36: 534-538.
17. George AA, Tsuchiyose M, Dooley CP. Sensitivity of the gastric mucosa to acid and duodenal contents in patients with nonulcer dyspepsia. Gastroenterology 1991; 101: 3-6.
18. Bates S, Sjoden PO, Fellenius J, Nyren O. Blocked and nonblocked acid secretion and reported pain in ulcer, nonulcer dyspepsia, and normal subjects. Gastroenterology 1989; 97: 376-383.
19. Waldron B, Cullen PT, Kumar R, et al. Evidence for hypomotility in non-ulcer dyspepsia: a prospective multifactorial study. Gut 1991; 32: 246-251.
20. Houghton LA, Mangnall YF, Read NW. Effect of incorporating fat into a liquid test meal on the relation between intragastric distribution and gastric emptying in human volunteers. Gut 1990; 31: 1226-1229.
21. Bartolotti M, Sarti P, Barbara L, Brunelli F. Gastric myoelectrical activity in patients with chronic idiopathic gastroparesis. J Gastrointest Motil 1990; 2: 104-108.
22. Mearin F, Cucala M, Azpiroz F, Malagelada JR. The origin of symptoms on the brain-gut axis in functional dyspepsia. Gastroenterology 1991; 101: 999-1006.
23. Holtmann G, Goebell H, Talley NJ. Impaired small intestinal peristaltic reflexes and sensory thresholds are independent functional disturbances in patients with chronic unexplained dyspepsia. Am J Gastroenterol 1996; 91: 485-491.
24. Coffin B, Azpiroz F, Guarner F, Malagelada JR. Selective gastric hypersensitivity and reflex hyporeactivity in functional dyspepsia. Gastroenterology 1994; 107: 1345-1351.
25. Barbera R, Feinle C, Read NW. Nutrient-specific modulation of gastric mechanosensitivity in patients with functional dyspepsia. Dig Dis Sci 1995; 40: 1636-1641.
26. Trimble KC, Farouk R, Pryde A, et al. Heightened visceral sensation in functional gastrointestinal disease is note site specific: evidence for a generalized disorder of gut sensitivity. Dig Dis Sci 1995; 40: 1607-1613.
27. Mertz H, Fass R, Kodner A, et al. Effect of amitriptyline on symptoms, sleep and visceral perception in patients with functional dyspepsia. Am J Gastroenterol 1998; 93: 160-165.
28. Bernersen B, Johnsen R, Bostad L, et al. Is Helicobacter pylori the cause of dyspepsia? BMJ 1992; 304: 1276-1279.
29. Schlemper RJ, van der Werf SD, Vandenbroucke JP, et al. Nonulcer dyspepsia in a Dutch working population and Helicobacter pylori. Ulcer history as an explanation of an apparent association. Arch Intern Med 1995; 155: 82-87
30. Mearin F, de Ribot X, Balboa A, et al. Does Helicobacter pylori infection increase gastric sensitivity in functional dyspepsia? Gut 1995; 37: 47-51.
31. Minocha A, Mokshagundam S, Gallo SH, Rahal PS. Alterations in upper gastrointestinal motility in Helicobacter pylori-positive nonulcer dyspepsia. Am J Gastroenterol 1994; 89: 1797-1800.
32. Talley NJ. A critique of therapeutic trials in Helicobacter pylori-positive functional dyspepsia. Gastroenterology 1994; 106: 1174-1183.
33. McCarthy C, Patchett S, Collins RM, et al. Long-term prospective study of Helicobacter pylori in nonulcer dyspepsia. Dig Dis Sci 1995; 40: 114-119.
34. Sheu BS, Lin Cy, Lin XZ, et al. Long-term outcome of triple therapy in Helicobacter pylori-related nonulcer dyspepsia: a prospective controlled assessment. Am J Gastroenterol 1996; 91: 441-447
35. Veldhuyzen van Zanten S, Malatjalian D, Tanton R, et al. The effect of eradication of Helicobacter pylori (Hp) on symptoms of non-ulcer dyspepsia (NUD) : a randomized double-blind placebo controlled trial [abstract]. Gastroenterology 1995; 108: A250.
36. Schutze K, Hentschel E, Hirschl AM. Clarithromycin or amoxycillin plus high-dose ranitidine in the treatment of Helicobacter pylori positive functional dyspepsia. Eur J Gastroenterol Hepatol 1996; 8: 41-46.
37. Laheij RJF, Jansen JBMJ, Vandelisdonk EH, Verbeek ALM. Symptom improvement through eradication of Helicobacter pylori with non-ulcer dyspepsia. Aliment Pharmacol Ther 1996; 10: 843-850.
38. Johnsen R, Bernersen B, Straume B, et al. Prevalences of endoscopic and histological findings in subjects with and without dyspepsia. BMJ 1991; 302: 749-752.
39. Drossman DA, Talley NJ, Leserman J, et al. Sexual and physical abuse and gastrointestinal illness. Review and recommendations. Ann Intern Med 1995; 123: 782-794.
40. Holtmann G, Singer MV, Kriebel R, et al. Differential effects of acute mental stress on interdigestive secretion of gastric acid, pancreatic enzyme and gastroduodenal motility. Dig Dis Sci 1989; 34: 1701-1707.
41. Scarinci IC, McDonald-Haile J, Bradley LA, Richter JE. Altered pain perception and psychosocial features among women with gastrointestinal disorders and history of abuse: a preliminary model. Am J Med 1994; 97: 108-118.
42. Talley NJ. Dyspepsia and heartburn - a clinical challenge. Aliment Pharmacol Ther 1997; 11 (Suppl 2): 1-8.
43. Axon ATR, Bell GD, Jones RH, et al. Guidelines on appropriate indications for upper gastrointestinal endoscopy. BMJ 1995; 310: 853-856.
44. 2-blocker therapy or prompt endoscopy in management of dyspepsia. Lancet 1994; 343: 811-816.
45. Patel P, Khulusi S, Mendall MA, et al. Prospective screening of dyspeptic patients by Helicobacter pylori serology. Lancet 1995; 346: 1315-1318.
46. McColl KEL, Elnujumi A, Murray L, et al. The Helicobacter pylori breath test - a surrogate marker for peptic ulcer disease in dyspeptic patients. Gut 1997; 40: 302-306.
47. Talley NJ. Functional dyspepsia - should treatment be targeted on disturbed physiology? Aliment Pharmacol Ther 1995; 9: 107-115.
48. Wysowski DK, Bacsanyi J. Cisapride and fatal arrhythmia. N Engl J Med 1996; 335: 290-291.
49. Kellow JE, Cowan·H, Shuter B, et al. Efficacy of cisapride therapy in functional dyspepsia. Aliment Pharmacol Ther 1995; 9: 153-160.
50. Chua AS, Bekkering M, Rovati LC, Keeling PW. Clinical efficacy and prokinetic effect of the CCK-A antagonist loxiglumide in nonulcer dyspepsia. Ann N Y Acad Sci 1994; 713: 451-453.
51. Talley NJ. Visceral analgesics and functional dyspepsia: have we found the Holy Grail? Gut 1997; 41: 717-718.
52. Dobrilla G, Comberlato M, Steele A, Vallaperata P. Drug treatment of functional dyspepsia. A meta-analysis of randomized controlled trials. J Clin Gastroenterol 1989; 11: 169-177.
53. Jones RH, Baxter G. Lansoprazole 30 mg daily versus ranitidine 150 mg b.d. in the treatment of acid-related dyspepsia in general practice. Aliment Pharmacol Ther 1997; 11: 541-546.
54. Bates S, Sjoden P, Nyren O. Behavioral treatment of non-ulcer dyspepsia. Scand J Behav Ther 1988; 17: 155-165.
55. Arn I, Theorell T, Uvnas Moberg K, Jonsson CO. Psychodrama group therapy for patients with functional gastrointestinal disorders - a controlled long-term follow-up study. Psychother Psychosom 1989; 51: 113-119.
56. Wiklund I, Glise H, Jerndal P, et al. Does endoscopy have a positive impact on quality of life in dyspepsia? Gastrointest Endosc 1998. In press.